Status:
UNKNOWN
Novel Dementia Biomarkers
Lead Sponsor:
German Center for Neurodegenerative Diseases (DZNE)
Collaborating Sponsors:
Otto-von-Guericke University Magdeburg
Conditions:
Alzheimer Disease, Early Onset
Eligibility:
All Genders
50-80 years
Brief Summary
The study will investigate structural and functional characteristics of the brain of dementia patients compared to healthy controls in order to get a better insight into importance of early biomarkers...
Eligibility Criteria
Inclusion
- Clinically diagnosed MCI patients and matched healthy controls
Exclusion
- Metal in body and tatoos;
- Other chronic systemic neurological, cardiologic, metabolic or musculo-skeletal diseases which have been proven to influence the outcome variables
- Alcohol abuse
- Colour blindness
- Pregnancy
- Surgery in the last 6 months
- Uncorrected vision
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04427436
Start Date
July 1 2020
End Date
December 31 2021
Last Update
June 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.